Key result
Beta-blockers remain one of the five major classes of antihypertensive drugs in European and national guidelines for the treatment of arterial hypertension, despite critical comments in some regions.
Why the study?
What is the role of beta-blockers in the treatment of arterial hypertension according to current guidelines?
What is the role of beta-blockers in the treatment of arterial hypertension according to current guidelines?
There is a divergence in international guidelines regarding the first-line use of beta-blockers for arterial hypertension, with European guidelines retaining them while US and UK guidelines have deprioritized them.
Beta-blockers retain major-class status in European guidelines; leaves open harmonization of international recommendations.
Beta adrenergic receptor blocking agentsare one of the multi-function classes of the drugs, prescribing to treatvarious cardio-vascular diseases, and at the same time, this class have been mostly discussing for several years due to the number of publications with the critical comments and rule this class of drugs out from priority groups for the treatment of arterial hypertension (AH), as, for example, it took place in the United Kingdom and the United States. However, national guidelines for the diagnosis and treatment of arterial hypertension (AH), as well as the guidelines from the European Society of Hyper- tension keep the same position on the β-blockers, including them on equal ground with list of 5 major classes of antihypertensive drugs to treat AH.
No takes yet. Share an insight, caveat, or question.
Zhernakova et al. (2015) conducted a review in Arterial hypertension. Beta-blockers was evaluated. Beta-blockers remain one of the five major classes of antihypertensive drugs in European and national guidelines for the treatment of arterial hypertension, despite critical comments in some regions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: